DMAA DCA Calculator
Dollar Cost Averaging — Drugs Made In America Acquisition Corp. Ordinary Shares
Historical data shows that a consistent $500 monthly investment into Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) starting in 2020 would have turned a total investment of $18K into $19K today. This represents a total return of 5.1% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Drugs Made In America Acquisition Corp. Ordinary Shares does not currently pay a notable dividend. For growth-focused stocks like DMAA, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $19K without the need for dividend reinvestment.
DMAA vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,DMAA underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $21K, compared to DMAA's $19K.